These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12510213)

  • 1. Neuroprotective effects of estradiol-17beta: implications for psychiatric disorders.
    Kölsch H; Rao ML
    Arch Womens Ment Health; 2002 Nov; 5(3):105-10. PubMed ID: 12510213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease.
    Amtul Z; Wang L; Westaway D; Rozmahel RF
    Neuroscience; 2010 Aug; 169(2):781-6. PubMed ID: 20493928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol and tamoxifen differentially regulate a plasmalemmal voltage-dependent anion channel involved in amyloid-beta induced neurotoxicity.
    Herrera JL; Fernandez C; Diaz M; Cury D; Marin R
    Steroids; 2011 Aug; 76(9):840-4. PubMed ID: 21354436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The female sex hormone oestrogen as neuroprotectant: activities at various levels.
    Behl C; Moosmann B; Manthey D; Heck S
    Novartis Found Symp; 2000; 230():221-34; discussion 234-8. PubMed ID: 10965511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of astrocytes in the neuroprotective actions of 17β-estradiol and selective estrogen receptor modulators.
    Acaz-Fonseca E; Sanchez-Gonzalez R; Azcoitia I; Arevalo MA; Garcia-Segura LM
    Mol Cell Endocrinol; 2014 May; 389(1-2):48-57. PubMed ID: 24444786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced cerebrospinal fluid estradiol levels are associated with increased beta-amyloid levels in female patients with Alzheimer's disease.
    Schönknecht P; Pantel J; Klinga K; Jensen M; Hartmann T; Salbach B; Schröder J
    Neurosci Lett; 2001 Jul; 307(2):122-4. PubMed ID: 11427315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is oestrogen neuroprotective?
    Agius M; Hockings H; Wilson C; Lane D
    Psychiatr Danub; 2009 Sep; 21 Suppl 1():120-7. PubMed ID: 19789496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estrogen on brain development and neuroprotection--implications for negative symptoms in schizophrenia.
    Rao ML; Kölsch H
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():83-96. PubMed ID: 12650683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17beta-Oestradiol stimulation of G-proteins in aged and Alzheimer's human brain: comparison with phytoestrogens.
    Jefremov V; Rakitin A; Mahlapuu R; Zilmer K; Bogdanovic N; Zilmer M; Karelson E
    J Neuroendocrinol; 2008 May; 20(5):587-96. PubMed ID: 18363809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17alpha-estradiol: a brain-active estrogen?
    Toran-Allerand CD; Tinnikov AA; Singh RJ; Nethrapalli IS
    Endocrinology; 2005 Sep; 146(9):3843-50. PubMed ID: 15947006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of 17alpha-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study.
    Dykens JA; Moos WH; Howell N
    Ann N Y Acad Sci; 2005 Jun; 1052():116-35. PubMed ID: 16024755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different methods for administering 17beta-estradiol to ovariectomized rats result in opposite effects on ischemic brain damage.
    Strom JO; Theodorsson E; Holm L; Theodorsson A
    BMC Neurosci; 2010 Mar; 11():39. PubMed ID: 20236508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of estrogen-depletion and 17beta-estradiol replacement therapy upon rat hippocampus beta-amyloid generation].
    Yang HQ; Sun ZK; Jiang QH; Shang Q; Xu J
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2658-61. PubMed ID: 20137687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormally rapid reversal learning and reduced response to antipsychotic drugs following ovariectomy in female rats.
    Arad M; Weiner I
    Psychoneuroendocrinology; 2012 Feb; 37(2):200-12. PubMed ID: 21723667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The loss of estrogen efficacy against cerebral ischemia in aged postmenopausal female mice.
    Cai M; Ma YL; Qin P; Li Y; Zhang LX; Nie H; Peng Z; Dong H; Dong HL; Hou WG; Xiong LZ
    Neurosci Lett; 2014 Jan; 558():115-9. PubMed ID: 24246902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in the adolescent developmental trajectory of parvalbumin interneurons in the hippocampus: a role for estradiol.
    Wu YC; Du X; van den Buuse M; Hill RA
    Psychoneuroendocrinology; 2014 Jul; 45():167-78. PubMed ID: 24845187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective actions of estradiol revisited.
    Azcoitia I; Arevalo MA; De Nicola AF; Garcia-Segura LM
    Trends Endocrinol Metab; 2011 Dec; 22(12):467-73. PubMed ID: 21889354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of the use of 17 β-estradiol and genistein in Alzheimer's disease in women with menopause].
    Chávez-Pérez C; Ceballos-Ramírez A; Suárez-Castro A
    Rev Esp Geriatr Gerontol; 2021; 56(4):236-240. PubMed ID: 34112537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and the brain: beyond ER-alpha, ER-beta, and 17beta-estradiol.
    Toran-Allerand CD
    Ann N Y Acad Sci; 2005 Jun; 1052():136-44. PubMed ID: 16024756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17beta-estradiol activates ICI 182,780-sensitive estrogen receptors and cyclic GMP-dependent thioredoxin expression for neuroprotection.
    Lee SY; Andoh T; Murphy DL; Chiueh CC
    FASEB J; 2003 May; 17(8):947-8. PubMed ID: 12626428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.